releases: https://cunningham.house.gov/media/press-releases/cunningham-releases-report-how-lower-drug-costs-now-act-will-deliver-relief
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://cunningham.house.gov/media/press-releases/cunningham-releases-report-how-lower-drug-costs-now-act-will-deliver-relief | Cunningham Releases Report on How Lower Drug Costs Now Act Will Deliver Relief to South Carolinians Facing High Drug Costs | 2019-12-09 | 2019 | 2019-12 | Democrat | House | SC | Joe Cunningham | C001122 | cunningham.house.gov | legacy | Washington, D.C. Today, Rep. Joe Cunningham (SC-01) released a report on how the Lower Drug Costs Now Act, H.R. 3, would reduce the cost of drugs for individuals in the Lowcountry. Cunningham is a cosponsor of this landmark legislation, which will be on the House floor for a vote later this week. H.R. 3 helps level the playing field, giving Medicare the power to negotiate directly with drug companies so that Americans no longer have to pay more than other countries for their medicines. It also makes the lower drug prices negotiated by Medicare available to Americans with private insurance, not just Medicare beneficiaries. All across the Lowcountry, I've heard from families struggling with the skyrocketing cost of prescription drugs. In fact, during the past year nearly 3 in 10 South Carolinians report having stopped taking medication as prescribed because of cost, said Rep. Joe Cunningham. This report clearly shows the significant impact the Lower Drug Cost Now Act would have on the Lowcountry. I urge my colleagues on both sides of the aisle to work together and get this bill signed into law. Nonpartisan analysis by the Congressional Budget Office (CBO) found that the legislation would reduce drug prices by up to 55% and save taxpayers $345 billion over 10 years. In the First District, there are 97, 279 people enrolled in a Medicare Part D plan and 585, 599 people enrolled in private health insurance, all of whom would stand to benefit from the Lower Cost Drugs Now Act. Other key highlights from the report: 11.5% of South Carolinians live with diabetes. Under H.R. 3, South Carolinians could spend 3.5 times less on insulin. H.R. 3 could lower the average total cost of a common insulin, the NovoLOG Flexpen, by 76%--from about $19,800 to $4,800 per year. In 2019, an estimated 4,470 women in South Carolina will be diagnosed with breast cancer. H.R. 3 can lower the average total cost of the breast cancer medication, Ibrance, by 65% from $69,000 to $23,900 per year. 26.3% of South Carolinians have arthritis, 36.7% of whom experience severe joint pain because of it. H.R. 3 can lower their total costs on most arthritis drugs from about $40,000 to $10,000 per year. About 9.2%or 361,086of South Carolinians live with asthma. H.R. 3 can lower their total costs on most asthma drugs from about $1,400 to $270 per year. One million people are living with Multiple Sclerosis (MS) in the United States. H.R. 3 can lower their total costs on most MS drugs from about $40,000 to $13,000 per year. You can find the full report here. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |